27 July 2017
CNH PhD Student Olivia Howells Success in KESS 2 Research Image Competition
Congratulations to Olivia Howells a CNH PhD student who won the 'Making Waves' KESS 2 research image competition. Olivia's research is focused on Microneedles, she explains "Transdermal delivery using a hypodermic needle is the routine technique used to administer vaccines. It offers many advantages such as rapid, low cost administration that avoids first pass metabolism. However, deep penetration through the skin, fat and muscle, stimulates pain, fear and reduces vaccine efficacy. Microneedles being only thousandths of a millimetre in length utilise the depth of the skin by only penetrating the outer layer, this allows a dose-sparing, direct immune response required for vaccination. Microneedles are ideal for patient self-administration as they by-pass nerve stimulation becoming pain free and do not require extensive training. Thus, my development of these microneedles offers the simplicity of effective, painless vaccinations that can be self-administered from home." Please click here for more details.
11 July 2017
Huge potential of nanotechnology closer to being unlocked through multi-million pound international project led by Swansea University
Scientists at Swansea University Medical School have just received approval from the European Commission for an international collaborative grant expected to be in excess of €12million to develop novel cutting-edge tests to prevent the use of animals when assessing safety concerns surrounding nanotechnology. Please click here for more details.
26 June 2017
Tiny nanoparticles offer significant potential in detecting and treating disease
Research led by Prof Steve Conlan of the Medical School into the potential medical uses of exosomes with the use of CNH facilities, please click here for more details.
12 June 2017
Sêr Cymru II Fellowships
Congratulations to Dr. Alex Lord, Dr Anitha Devadoss, and Dr Zari Tehrani members of our CNH research staff who have been awarded Sêr Cymru II Fellowships which is Part-funded by the European Regional Development Fund through the Welsh Government. The projects will be focused across various sensor technology platforms, for more information about the Fellows and their projects please click here.
5 June 2017
Global fight against hepatitis boosted by UK and China research collaboration on new graphene sensor for swifter diagnosis.
Researchers from institutions in China and the UK, including Swansea University, are collaborating on a project to develop a graphene-based sensor, which aims to provide an easy, low-cost way of diagnosing hepatitis on-the-spot.
The two-year, multi-partner project, which is funded by the UK’s Newton Fund and led by Swansea-based BIOVICI, developing the next generation of point-of-care (POC) diagnostic devices, brings together the National Physical Laboratory (NPL), the UK’s National Measurement Institute; the University of Chongqing; Swansea University’s Centre for NanoHealth; and industry partner CTN.
Professor Owen Guy, Director (Engineering) at the Centre for Nanohealth at Swansea University, said: “Using semiconductor process technology applied to graphene enables us to make low-cost sensors. With the right lab-on-chip technology, there is the potential to develop sensors for a host of diagnostic and screening applications”
24 April 2017
The CALIN project is set to push boundaries in the life-science sector following its hugely successful launch events in Ireland and Wales last month. The Irish launch event at Tyndall National Institute showcased a range of expertise including cell biology, nanomedicine, wearable sensor systems and smart implants.
One of the SMEs involved in the CALIN event at Tyndall was Jellagen, a Pembrokeshire based SME who produce collagen products sourced from jellyfish. Jellagen are currently working on a collaborative project with Swansea Universities Centre for Nanohealth and NUI Galway. Andrew Mearns Spragg, CEO of Jellagen, said about the event:
“The CALIN event provided a fantastic platform to network with a range of academic and industrial colleagues. Jellagen is excited to be part of the CALIN project and we look forward to working with our partners to develop robust research into products with real commercial potential”
16 February 2017
Professor Owen Guy, Director of the Centre for NanoHealth (CNH) at Swansea University shares a major €3.5 M grant win from the H2020 Marie Curie Training Network.
As one of the eleven partner institutions led by Plymouth University, a fund of £470,000 is granted for Wales-based research at Swansea Universities CNH.
Professor Guy said “This grant represents a unique opportunity to link with leading European research groups and industry partners, to develop diagnostic technology related to Alzheimer’s disease. The Marie Curie Training Network programme will also deliver a generation of 13 highly-skilled, creative and entrepreneurial Fellows across the network, setting them on a path to successful careers in academia or industry” Please click here for full article.
20 January 2017
Research scientists at Swansea University are helping to meet the challenge of incorporating nanoscale structures into future semiconductor devices that will create new technologies and impact on all aspects of everyday life. Read more